BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3520886)

  • 1. In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis.
    Martin DH; Pastorek JG; Faro S
    Sex Transm Dis; 1986; 13(2):81-7. PubMed ID: 3520886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.
    Bowie WR
    Antimicrob Agents Chemother; 1986 Apr; 29(4):713-5. PubMed ID: 3707116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticarcillin disodium/clavulanate potassium versus clindamycin/gentamicin in the treatment of postpartum endometritis.
    Faro S; Martens M; Phillips LE; Hamill H; Smith D; Riddle G
    J Reprod Med; 1988 Jun; 33(6 Suppl):603-6. PubMed ID: 3294407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticarcillin/clavulanic acid versus clindamycin and gentamicin in the treatment of post-cesarean endometritis following antibiotic prophylaxis.
    Faro S; Martens M; Hammill H; Phillips LE; Smith D; Riddle G
    Obstet Gynecol; 1989 May; 73(5 Pt 1):808-12. PubMed ID: 2704510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
    Downes J; Andrew JH
    Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic therapy for pelvic inflammatory disease.
    Pastorek JG
    J Reprod Med; 1990 Mar; 35(3 Suppl):329-32. PubMed ID: 2181120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis.
    Hammerschlag MR; Gleyzer A
    Antimicrob Agents Chemother; 1983 Mar; 23(3):493-4. PubMed ID: 6847175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology and treatment of post-cesarean-section endometritis after cephalosporin prophylaxis.
    Hillier S; Watts DH; Lee MF; Eschenbach DA
    J Reprod Med; 1990 Mar; 35(3 Suppl):322-8. PubMed ID: 2181119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
    Chattopadhyay B; Hall I; Curnow SR
    Curr Med Res Opin; 1983; 8(8):577-81. PubMed ID: 6653135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    Betriu C; Sánchez A; Gómez M; Palau ML; Picazo JJ
    J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection in women. Clinical experience with beta-lactamase inhibitors.
    Holloway WJ
    J Reprod Med; 1988 Jun; 33(6 Suppl):595-7. PubMed ID: 3294405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious disease relations to cesarean section.
    Faro S
    Obstet Gynecol Clin North Am; 1988 Dec; 15(4):685-95. PubMed ID: 3226672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F; Li J; Gao L; Chen Y
    Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis.
    Sirinek KR; Levine BA
    Surg Gynecol Obstet; 1991; 172 Suppl():30-5. PubMed ID: 2024224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.